Carregando...
Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin
OBJECTIVE: To examine the mechanisms responsible for improved glycemia with combined sodium–glucose cotransporter 2 inhibitor (SGLT2i) plus dipeptidyl peptidase 4 inhibitor therapy in type 2 diabetes. RESEARCH DESIGN AND METHODS: Fifty-six patients (HbA(1c) 8.9 ± 0.2% [74 ± 2 mmol/mol]) were randomi...
Na minha lista:
| Publicado no: | Diabetes Care |
|---|---|
| Principais autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Diabetes Association
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7510028/ https://ncbi.nlm.nih.gov/pubmed/32694214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1993 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|